Table 2 (abstract A80).
Medications at baseline for patients with DLE (Skin-Limited and SLE). Topical steroids and hydroxychloroquine were most frequently prescribed
| Medication | N, (%) |
|---|---|
| Topical steroids | 132 (65%) |
| Hydroxychloroquine | 118 (58%) |
| Other immunomodulatory medications | 59 (29%) |
| • Prednisone/Methylprednisolone | 46 (22%) |
| • Mycophenolate mofetil | 16 (8%) |
| • Rituximab | 5 (2%) |
| • Methotrexate | 4 (2%) |
| • Dapsone | 4 (2%) |
| • Azathioprine | 4 (2%) |
| • Quinacrine | 1 (0.5%) |
| • Thalidomide | 1 (0.5%) |
| Topical calcineurin inhibitors | 40 (20%) |
| None | 13 (6%) |